Ledger.Open graph →
SEC Form D · filed December 20, 2022

SYNAPSE BIOMEDICAL INC

Offering
$810K
Sold
Exemption
Rule 506(b)
Industry
Biotechnology
Location
OBERLIN, OH
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Anthony R. Ignagni · Oberlin, OHExec · DirectorRaymond P. Onders · Oberlin, OHDirectorAnthony S. Glover · NEW YORK, NYExec · DirectorJames M. Wesley · NEW YORK, NYDirectorKiyotaka P. Mori · Oberlin, OHDirectorMoustapha P. Diop · Oberlin, OHExec · DirectorJohn P. Krystowski · Oberlin, OHDirectorChris Owens · Watertown, SDExec · DirectorBrendan Corcoran · Wilmington, DEDirectorKiyotaka P. Mori · Oberlin, OHDirectorMoustapha P. Diop · Oberlin, OHExec · DirectorJohn P. Krystowski · Oberlin, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗